PEPPY HEALTH LIMITED
Get an alert when PEPPY HEALTH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-12-18 (in 7mo)
Last made up 2025-12-04
Watchouts
None on the register
Cash
£2M
-85.8% vs 2023
Net assets
-£6M
-994.4% lowest in 4 filed years
Employees
102
-47.4% vs 2023
Profit before tax
-£7M
+51.6% vs 2023
Net assets
4-year trend · vs Technology median
Accounts
4-year trend · latest reflected 2024-12-31
| Metric | Trend | 2019-10-31 | 2020-10-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Turnover | — | — | £8,968,599 | £10,358,430 | |
| Operating profit | — | — | -£13,961,717 | -£5,431,542 | |
| Profit before tax | — | — | -£14,137,592 | -£6,849,438 | |
| Net profit | — | — | -£14,137,592 | -£6,783,165 | |
| Cash | £114,307 | £1,099,405 | £11,600,053 | £1,646,669 | |
| Total assets less current liabilities | £123,795 | £1,246,759 | £5,685,081 | -£1,255,258 | |
| Net assets | — | — | £676,099 | -£6,046,921 | |
| Equity | £123,795 | £1,246,759 | £676,099 | -£6,046,921 | |
| Average employees | 3 | 5 | 194 | 102 | |
| Wages | — | — | £13,372,988 | £8,504,513 | |
| Directors' remuneration | — | — | £668,816 | £597,419 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+15.5%
£8,968,599 £10,358,430
-
Cash
-85.8%
£11,600,053 £1,646,669
-
Net assets
-994.4%
£676,099 -£6,046,921
-
Employees
-47.4%
194 102
-
Operating profit
+61.1%
-£13,961,717 -£5,431,542
-
Profit before tax
+51.6%
-£14,137,592 -£6,849,438
-
Wages
-36.4%
£13,372,988 £8,504,513
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-10-31 | 2020-10-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Operating margin | — | — | -155.7% | -52.4% | |
| Net margin | — | — | -157.6% | -65.5% | |
| Return on capital employed | — | — | -245.6% | 432.7% | |
| Gearing (liabilities / total assets) | — | — | 95.5% | 215.8% | |
| Current ratio | — | — | 1.42x | 0.58x | |
| Interest cover | — | — | -21.64x | -3.31x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- Azets Audit Services
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements are prepared on a going concern basis, which assumes the Group will continue in operational existence for the foreseeable future. The Group's ability to meet its future working capital requirements and therefore continue as a going concern is dependent upon it being able to generate significant revenues and free cash flow.”
Group structure
- PEPPY HEALTH LIMITED · parent
- Peppy Health Corporation 100%
Significant events
- “Subsequent to the reporting date, on 16 May 2025, the Group discontinued development of its Platform business. All related assets, liabilities and resources were carved out into a newly incorporated entity, Euphoric Global Limited, for a nominal consideration of £1.”
- “As part of the transaction, Peppy Health Limited made a cash investment of £298,995 in Euphoric Global Limited and, in return, received a 18.2% equity stake in the entity. Together with Albion VC this represented a total investment of £304,786 and a 20.0% equity stake.”
- “As part of the restructure post year-end, the revolving credit facility with NatWest Bank was amended to £6,500,000 in line with revised funding requirements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| NAVARRE GIRAULT, Nicole Suzanne | Secretary | 2024-01-24 | — | — |
| CHONG, Kevin Kian Ming | Director | 2020-09-07 | Feb 1972 | British |
| LIN, Sinan | Director | 2021-07-08 | Apr 1986 | Australian |
| PORE, Mridula, Dr | Director | 2019-01-19 | Sep 1981 | British |
| WILSON, Jay | Director | 2022-12-05 | Dec 1983 | British |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HARRIS, Evan Brendan | Director | 2018-08-23 | 2025-06-09 |
| TROTTER-LANDRY, Maximilian Harry | Director | 2018-08-23 | 2025-06-09 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr Mridula Pore | Individual | Shares 25–50%, Voting 25–50% | 2018-10-01 | Ceased 2021-07-05 |
| Mr Maximilian Harry Trotter-Landry | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2018-08-23 | Ceased 2021-07-05 |
| Mr Evan Brendan Harris | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2018-08-23 | Ceased 2021-07-05 |
Filing timeline
Last 20 of 113 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-11-25 MA Memorandum articles
- 2025-10-28 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-07 | SH01 | capital | Capital allotment shares | |
| 2026-04-20 | RP01CS01 | confirmation-statement | Replacement filing of confirmation statement with made up date | |
| 2026-04-20 | RP01CS01 | confirmation-statement | Replacement filing of confirmation statement with made up date | |
| 2026-04-20 | RP01CS01 | confirmation-statement | Replacement filing of confirmation statement with made up date | |
| 2026-04-20 | RP01CS01 | confirmation-statement | Replacement filing of confirmation statement with made up date | |
| 2026-04-20 | RP01CS01 | confirmation-statement | Replacement filing of confirmation statement with made up date | |
| 2026-01-27 | AD01 | address | Change registered office address company with date old address new address | |
| 2026-01-09 | SH01 | capital | Capital allotment shares | |
| 2025-12-18 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-11-25 | MA | incorporation | Memorandum articles | |
| 2025-11-21 | SH10 | capital | Capital variation of rights attached to shares | |
| 2025-11-21 | SH08 | capital | Capital name of class of shares | |
| 2025-10-28 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2025-10-28 | SH20 | capital | Legacy | |
| 2025-10-28 | CAP-SS | insolvency | Legacy | |
| 2025-10-28 | RESOLUTIONS | resolution | Resolution | |
| 2025-10-01 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-09-25 | AA | accounts | Accounts with accounts type group | |
| 2025-09-04 | SH01 | capital | Capital allotment shares | |
| 2025-07-24 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 20
- Capital events
- 8
- Officers appointed
- 0
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.